GLS and neoplasm: To assess whether the reduced expression of immunomodulatory molecules upon ZBTB18 expression affects the recruitment of immune cells in the tumor area, sections of BTSC233-derived mouse tumors generated in our former study16 were stained for the GAM marker IBA1, which labels both microglia and macrophages.